Malami et al. [54] found that elevated γ-H2AX expression in HCC after liver transplantation is linked to tumor aggressiveness and poor prognosis, indicating its significance as a therapeutic target and prognostic marker. The gene discussed is H2AX; the disease is hepatocellular carcinoma.